Anti–activated protein C antibodies were present (i.e., levels more than 3 SD above the mean in healthy controls) in 5 (15.6%) of the APS patients and 2 (15.4%) of the SLE/aPL+ patients. The gene discussed is FASLG; the disease is systemic lupus erythematosus.